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Abstract
Background: Post-implantation therapies to optimize cardiac resynchronization therapy (CRT) focus on adjustments of the
atrio-ventricular (AV) delay and ventricular-to-ventricular (VV) interval. However, there is little consensus on how to achieve
best resynchronization with these parameters. The aim of this study was to examine a novel combination of doppler
echocardiography (DE) and three-dimensional echocardiography (3DE) for individualized optimization of device based AV
delays and VV intervals compared to empiric programming.
Methods: 25 recipients of CRT (male: 56%, mean age: 67 years) were included in this study. Ejection fraction (EF), the
primary outcome parameter, and left ventricular (LV) dimensions were evaluated by 3DE before CRT (baseline), after AV
delay optimization while pacing the ventricles simultaneously (empiric VV interval programming) and after individualized
VV interval optimization. For AV delay optimization aortic velocity time integral (AoVTI) was examined in eight different AV
delays, and the AV delay with the highest AoVTI was programmed. For individualized VV interval optimization 3DE full-
volume datasets of the left ventricle were obtained and analyzed to derive a systolic dyssynchrony index (SDI), calculated
from the dispersion of time to minimal regional volume for all 16 LV segments. Consecutively, SDI was evaluated in six
different VV intervals (including LV or right ventricular preactivation), and the VV interval with the lowest SDI was
programmed (individualized optimization).
Results: EF increased from baseline 2367% to 3068( p ,0.001) after AV delay optimization and to 3268% (p,0.05) after
individualized optimization with an associated decrease of end-systolic volume from a baseline of 138660 ml to 115642 ml
(p,0.001). Moreover, individualized optimization significantly reduced SDI from a baseline of 14.365.5% to 6.162.6%
(p,0.001).
Conclusions: Compared with empiric programming of biventricular pacemakers, individualized echocardiographic
optimization with the integration of 3-dimensional indices into the optimization protocol acutely improved LV systolic
function and decreased ESV and can be used to select the optimal AV delay and VV interval in CRT.
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Introduction
Despite progress in the treatment of heart failure the five year
mortality still remains over 50% [1]. About one third of patients
with heart failure show a widened QRS complex ($120 ms) as a
sign of conduction system disease [2],[3]. Cardiac resynchroniza-
tion therapy (CRT) has evolved as the treatment of choice for
patients with symptomatic heart failure, left bundle branch block/
QRS widening ($120 ms) and severely reduced systolic left
ventricular (LV) function despite optimal medical therapy. Large
studies showed that CRT not only improves quality of life and LV
systolic function [4,5,6] but also leads to a reduction in mortality
[7]. Nevertheless up to one third of patients, so called non-
responders, do not symptomatically respond to this therapy
[8,9,10,11]. The exact reasons for lack of response are still
unclear, but inadequate lead placement, scar burden, and also
device settings may contribute.
Several studies showed that increased scar burden, especially in
the postero-lateral LV segments, the preferred region of the LV
lead positioning, may lead to suboptimal clinical outcome
[12,13,14]. This may be due to regional variations in electrical
excitability and impulse propagation in proximity of the lead.
Transvenous LV lead implantation is limited by the individual
anatomy of the tributaries of the coronary sinus and sometimes by
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Thus, if one takes into account potential suboptimal LV lead
placement, electrical latency during LV stimulation and slowed
conduction due to scars near the LV pacing site, all possibly
contributing to a reduced response to CRT, an individualized
approach to programming CRT systems, with the possibility of
pre-activation of either one of the ventricular leads, is intriguing.
In the clinical setting programming of CRT systems is
frequently done empirically [15], using an AV delay of 120 ms
and simultaneous biventricular pacing, without further optimiza-
tion.
In small studies it has been shown that optimized programming
of the AV delay leads to improved hemodynamics, as well as to
improved symptomatic response and LV systolic function in the
short and the longer term [16,17],[18,19,20]. As with AV delay,
acute hemodynamic benefits [21,22], as well as symptomatic and
echocardiographic advantages in the longer term [23,24] have
been described with interventricular VV interval optimization.
There are scarce studies that evaluated the effect of a combined
approach of AV delay and VV interval optimization [25,26].
The AV delay may be optimized with Doppler echocardiogra-
phy by evaluating the aortic velocity time integral (AoVTI), which
serves as a surrogate for LV stroke volume [18,27,28]. Three
dimensional echocardiography (3DE) is an accurate and repro-
ducible method to quantify LV dyssynchrony [29]. It is unclear if
an elaborate echocardiographic approach to AV delay and VV
interval optimization of CRT systems, including doppler echocar-
diography (AV delay optimization) and three-dimensional echo-
cardiography (VV interval optimization), leads to an improved
acute outcome after CRT initiation.
In the present study we therefore evaluated the feasibility of
three-dimensional echocardiography (3DE) to optimize the inter-
ventricular interval of biventricular pacemakers.
Methods
Ethics statement
All patients included in this study gave written informed consent
prior to entry into the study. The study complies with the
principles of the Declaration of Helsinki and was approved by the
institutional ethics committee of Deutsches Herzzentrum
Mu ¨nchen, Technical University of Munich, the only institution,
where participants were recruited and this study was conducted
(Az 2608/09; 10.12.2009).
Study design
In this study we prospectively included patients who underwent
CRT implantation according to 2006 guidelines [30] (ejection
fraction ,35%, New York Heart Association (NYHA) functional
class III or IV despite optimal pharmacological therapy, and QRS
duration .120 ms). At the time of inclusion baseline parameters
were assessed (medication status, ECG, and echocardiography).
All patients underwent a comprehensive evaluation with 3D
echocardiography before implantation (baseline). The day after
implantation the device was optimized as described below. Finally,
LV function was again assessed echocardiographically.
Echocardiography
Routine baseline 2D and 3D echocardiography (Philips iE33)
were performed in all patients according to institutional guidelines.
3D echocardiography was performed using the X3-1 matrix
transducer. Apical views were optimized to allow complete
visualization of the left ventricle in the 4- and 2-chamber views.
During breath-hold a complete 3D volume was acquired during 7
to 8 cardiac cycles. Angle and depth were minimized to ensure
optimal temporal resolution while still acquiring the entire LV
volume. The volume data were sent to a workstation for off-line
processing and analysis (QLab v. 6.0, Philips), using the 3DQ-
Advanced plugin. The software allows semi-automated delineation
of end-systolic and end-diastolic endocardial borders (Figure 1).
Through automated sequential tracking throughout the cardiac
cycle the software creates a dynamic 3D model of the left
ventricular cavity. The software calculates ejection fraction, end-
diastolic and end-systolic volumes, as well as the systolic
dyssynchrony index (SDI). The latter is calculated as the standard
deviation of the time to minimal systolic volume (TmSv) in 16
segments, excluding the apical cap in a standard 17-segment
model. The SDI is corrected for the RR interval and is expressed
as a percentage (Figure 1).
Echocardiographic guided optimization of the CRT device was
performed the day after implantation. First, AV delays were
analyzed from 80 to 200 ms, with steps of 20 ms. Aortic flow was
recorded as a velocity-time integral (AoVTI) using continuous-
wave Doppler at the level of the aortic valve, according to the
consensus statement of the American Society of Echocardiography
[31]. Subsequently, the AV delay with the highest velocity-time
integral was programmed. Interventricular intervals between the
right and left ventricles (VV intervals) were analyzed at 5 different
intervals: simultaneous stimulation (LV=RV), left-ventricular pre-
activation (LV +20, LV +40 ms), and right-ventricular pre-
activation (RV +20, RV +40 ms). For each of the tested intervals
a complete 3D full volume was acquired. Analysis of the 3D
volume data was done off-line in a blinded fashion by 2
independent investigators. The device was programmed for the
VV interval with the lowest SDI (Figure 1).
Statistical analysis
All continuous variables are expressed as mean 6 standard
deviation. Presence of a normal distribution was evaluated by
Kolmogorov-Smirnov test, means were compared by paired t-test.
Where a non-parametric distribution was assumed, Wilcoxon test
was performed. Categorical variables were tested by the chi-square
test. To assess intra- and inter-observer variabilities, intra-class
correlations (ICC) were calculated, and the variability is expressed
as the absolute difference between 2 measurements divided by the
average of the 2 measurements. Resulting p-values,0.05 were
considered statistically significant.
Results
Baseline characteristics
A total of 25 patients were included in the study. The mean age
was 67 years with 56% males (Table 1). 56% had ischemic
cardiomyopathy as the underlying cause of heart failure. Further
baseline characteristics are given in Table 1.
AV delay optimization
For AV delay optimization aortic velocity time integral (AoVTI)
was examined in eight different AV delays, and the AV delay with
the highest AoVTI was programmed. Aortic flow increased from
baseline 2467c m t o 2 7 69 cm after AV delay optimization
(p,0.05). The optimal mean sensed AV delay programmed was
108 ms [80–140 ms] and the optimal paced AV delay pro-
grammed was 133 ms [120–140 ms]. The SDI improved
significantly from 14.365.5% to 9.064.6%, as well as the EF,
which rose from a baseline value of 2367% to 3068% after AV
delay optimization (Table 2, Figure 2).
3D-Echocardiography Guided CRT-Optimization
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After AV delay optimization, the VV intervals were analyzed by
evaluating the 3D full volume datasets. For each VV interval a
separate 3D dataset was analyzed. The VV interval with the lowest
corresponding SDI was used for programming the device.
We observed a further decrease in SDI values from 9.064.6%
to 6.162.6% (Table 2). In most patients either simultaneous
activation of left and right ventricle or mild pre-activation of the
left ventricle resulted in the smallest SDI value (simultaneous
activation in 28%, LV pre-activation by 20 ms in 48% of all
patients). In 3 patients LV pre-activation by 40 ms, and in 3
patients right ventricular pre-activation by 20 ms led to the best
SDI, and were programmed accordingly. Interestingly, the
ejection fraction increased from 2367% before pacemaker
implantation to 3068% after AV delay optimization and we
could observe a further significant improvement after VV interval
optimization (after complete optimization: 3268%). The aortic
VTI, which rose from baseline 2467t o2 7 69c m a f t e r A V
optimization, remained unchanged after VV interval optimiza-
tion (266 cm). The end-diastolic volume fell from baseline
176662 ml to 166648 ml after complete optimization. The end-
systolic volume also showed a significant reduction (baseline
138660 ml, after complete optimization 115642 ml; Table 2,
Figure 2).
Figure 1. 3D-echocardiography guided optimization of cardiac resynchronization therapy. Patient with ischemic cardiomyopathy,
severly reduced systolic left ventricular (LV)-function (EF 16.8%), left bundle branch block and dyspnea on exertion (NYHA class III) selected for cardiac
resynchronisation therapy (CRT) before biventricular pacemaker implantation: A) tracing of the LV endocardial boundary in the multiple apical and
short axis views. From these datasets a volumetric model of the left ventricle is drawn (B), and time-volume curves are automatically integrated for
each segment: C) time-volume curves of the patient before pacemaker implantation (upper panel); immediately after implantation (middle panel);
after complete echocardiographic optimization (lower panel). Shown are the respective SDI values after each optimization step.
doi:10.1371/journal.pone.0030964.g001
3D-Echocardiography Guided CRT-Optimization
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standard setting of simultaneous activation of left and right
ventricle. 86% of patients with ischemic cardiomyopathy needed
pre-activation versus only 55% of patients with dilated cardiomy-
opathy (p,0.05, Figure 3).
Intra- and inter-observer agreement
The intra- and inter-observer agreement was generally very
good.
Intra-observer variability in measured SDI was 1468%. Intra-
observer variability in ejection fraction, end-diastolic volume, and
end-systolic volume was 362%, 262%, and 363%, respectively.
Intra-class correlation coefficients were 0.974 for SDI, 0.997 for
EF, 0.998 for EDV and 0.998 for ESV.
Inter-observer variability in measured SDI was 17614%. Inter-
observer variability in ejection fraction, end-diastolic volume, and
end-systolic volume was 866%, 364%, and 463%, respectively.
Intra-class correlation coefficients were 0.948 for SDI, 0.981 for
EF, 0.997 for EDV and 0.996 for ESV.
Discussion
In the present study we tested a new protocol of combined AV
delay and VV interval optimization of CRT-systems including
standard Doppler-echocardiography for AV delay, and 3D
echocardiography for VV interval optimization. This elaborate
protocol led to a significant improvement of LV function
immediately after implantation of a CRT device compared to
empiric device programming. The examined cohort existed of
typical candidates for cardiac resynchronization therapy. All were
highly symptomatic and on recommended optimal pharmacolog-
ical therapy. Moreover, all patients showed QRS prolongation of
more than 120 ms, and had a mean ejection fraction of 23%.
After the first step of optimization (AV delay optimization) the
ejection fraction rose from 23% to 30% and could be increased
even further by VV interval optimization (32%). End-systolic
volume was reduced significantly already after AV delay
optimization, with a moderate further reduction after VV interval
optimization. The SDI, as a marker of interventricular dyssyn-
chrony, fell sharply after each optimization step, whereas the
aortic VTI, a surrogate marker of stroke volume, was only affected
by AV delay optimization. In most patients the VV interval had to
be programmed differently from the standard setting (i.e.
simultaneous activation of left and right ventricle), only 28% of
patients achieved the lowest possible SDI with the standard setting
of simultaneous activation of left and right ventricle.
These results strongly support an individualized optimization of
CRT-systems, specifically tailored to the patients. CRT is used in
patients with several etiologies of severely symptomatic heart
failure [9] [32], and one can imagine that a one fits all approach
may not necessarily generate the best outcome. This has also been
shown in a small cohort with Doppler optimization of AV delay
and VV interval. Favorable hemodynamic response was more
pronounced in the group of patients randomized to the
optimization protocol [33].
This is the first study to use 3DE for VV interval optimization.
The only modest further improvement of LV-EF after VV interval
optimization in addition to AV optimization was lower than
Table 1. Baseline characteristics.
N=25
Demographic data
Age, years 67611
Male sex 14 (56%)
Clinical data
NYHA class 3 22 (88%)
NYHA class 4 3 (12%)
Ischemic CMP 14 (56%)
Medication
Betablockers 23 (92%)
ACE-inhibitors/ARBs 23 (92%)
Diuretics 24 (96%)
Aldosterone antagonists 18 (72%)
Digitalis 3 (12%)
Statins 25 (100%)
Electrocardiographic data
QRS width, ms (median; IQR) 160 (122–198)
Echocardiographic data
LV end-diastolic volume, ml 176662
LV end-systolic volume, ml 138660
LVEF, % 2367
SDI, % 14.365.5
Values are shown as means 6 standard deviation or count (percentage).
NYHA, New York Heart Association; CMP, cardiomyopathy; ACE, Angiotensin-
converting enzyme; ARB, Angiotensin receptor blocker; LV, left ventricle; SDI,
systolic dyssynchrony index.
doi:10.1371/journal.pone.0030964.t001
Table 2. Echocardiographic parameters at baseline and after AV delay and VV interval optimization.
Baseline After AV delay optimization After complete optimization
LV end-diastolic volume, ml 176662 168650 166648
LV end-systolic volume, ml 138660 121648{ 115642"*
Ejection fraction, % 23673 0 68{ 3268"*
SDI, % 14.365.5 9.064.{ 6.162.6"*
Aortic VTI, cm 24672 7 69{ 2668*
SDI, systolic dyssynchrony index; AV, atrio-ventricular; VV, ventriculo-ventricular; LV, left ventricular; VTI, velocity-time integral.
Shown are means 6 standard deviation.
{p,0.001: for comparison of AV optimization vs baseline.
"p,0.05: for comparison of complete optimization vs AV optimization only.
*p,0.05: for comparison of complete optimization vs baseline.
doi:10.1371/journal.pone.0030964.t002
3D-Echocardiography Guided CRT-Optimization
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dyssynchrony index (SDI) with each optimization step was striking
and may lead to further improvement of LV-EF in the long-term.
It is also known from a small study by Valzania et al. [34], that
hemodynamic parameters tend to change over the course of
several months after CRT. So, it would be very interesting, if these
modest changes in EF immediately after implantation translate
into robust changes later on in the course. Further follow-up has to
clarify this issue.
The positive acute results are especially encouraging as LV
resynchronization acutely after the implantation of biventricular
pacemakers predicts response to CRT in the long-term [35].
Moreover a recent study by Kapetanakis et al. emphasized the
relevance of the left ventricular systolic dyssynchrony index (SDI)
with respect to patient selection for CRT [36]. They found SDI to
be highly predictive of response to CRT, in terms of functional
(NYHA functional class) and echocardiographic (LV-EF and LV
end-systolic volume) improvement. Similarily, we found a trend
towards more pronounced acute echocardiographic response with
the suggested cutoff value for the baseline SDI of 10.4% (change in
EF: 7 +/2 5% in the low SDI vs 10 +/2 4% in the high SDI
subgroup, p=0.1; change in ESV: 213 +/2 13 ml in the low vs.
226 +/2 30 ml in the high SDI subgroup, p=0.2). Future studies
should investigate if this highly promising optimization technique
combined with improved selection criteria including an SDI cut-
off would translate into improved functional outcome.
Furthermore, AV delay optimization can maximize the benefits
of cardiac resynchronization therapy. If programmed poorly, it
may curtail beneficial effects of VV interval optimization and of
CRT in general. Optimized AV synchrony is achieved by an AV
delay that provides the best left atrial contribution to LV filling
resulting in maximum stroke volume. Several echocardiographic
methods have been used for AV delay optimization [16,17]. In our
study, we used the aortic VTI Doppler method to optimize the AV
delay. It produces reproducible results and has been shown to be
superior to the mitral inflow method [37].
VV interval optimization has been attempted with several
techniques with varying success [21,22,24,25,33,38]. The high
percentage of patients with sequential inter-ventricular pacing as
the optimal setting is in concordance with other studies that
evaluated VV interval optimization [22,23,24,25,39].
The SDI seems to be a promising parameter for VV interval
optimization, as it may help to overcome the problems arising
from LV-lead latency and from slowed conduction due to
increased scar burden in patients with ischemic cardiomyopathy
[13,14]. Simultaneous pacing of both ventricles may result in
suboptimal resynchronization due to an unbalanced activation of
right ventricular and left ventricular wavefronts. SDI helps in
finding and programming the optimal VV interval with either left
or right ventricular pre-activation to compensate for these
challenges and thus resulting in a more synchronous mechanical
activation of both ventricles. Moreover, in a patient where the only
Figure 2. Acute hemodynamic effects of 3D-echocardiography guided optimization. Hemodynamic variables for each timestep of the
optimization protocol: A) systolic dyssynchrony index, B) ejection fraction, and C) left-ventricular end-diastolic and end-systolic volumes. Shown are
means 6 standard deviation. * p,0.05 vs. baseline values.
doi:10.1371/journal.pone.0030964.g002
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[40] pre-activation of either one of the ventricles may give the
additional time to achieve synchronous mechanical activity. This
applies predominantly to patients with ischemic cardiomyopathy
where optimal lead placement might not be possible due to
increased scarring in the area of the accessible veins. As has been
previously shown by van Gelder et al. [39] we found that patients
with ischemic cardiomyopathy needed more pre-activation than
patients with dilated cardiomyopathy. 86% of patients with
ischemic cardiomyopathy needed pre-activation versus only 55%
of patients with dilated cardiomyopathy (p,0.05). Interestingly,
patients with ischemic cardiomyopathy more often needed pre-
activation of the right ventricle or extreme pre-activation of the left
ventricle (.20 ms), whereas pts with dilated cardiomyopathy only
needed slight to moderate pre-activation of the left ventricle
(Figure 3) [41].
Although this optimization technique is more sophisticated and
thus slightly more time consuming as compared to traditional
echocardiographic optimization protocols due to offline analysis, it
can be easily integrated into the usual workflow of post-operative
CRT treatment in a patient with a hospital stay of 3 to 4 days.
Images can be obtained postoperatively, AV delay programmed
immediately and VV interval programmed after offline analysis
before discharge from the hospital.
Several limitations apply to our study. This was a small study to
evaluate a new concept of optimized resynchronization therapy.
There was no control group in this study. Moreover no
assumptions regarding the long-term benefit can be made. This
has to be addressed in an adequately powered, prospective trial.
The resolution of most 3D ultrasound scanners is still reduced
compared to standard 2D technology. Especially, temporal
resolution is still a major issue, leading to high variability of the
measurements. This could hamper the analysis of small-scale
variations of ventricular dyssynchrony and could thus influence the
parameter setting with respect to the VV synchronization. Future
technical improvements of 3D scanners might improve temporal
as well as spatial resolution and lead to more reliable results.
Conclusion
In the present study we could demonstrate, that an individu-
alized echocardiographic optimization with the integration of 3-
dimensional indices into the optimization protocol significantly
improves LV function in CRT compared to empiric VV interval
programming. This novel individualized echocardiographic opti-
mization protocol can be used to select the optimal AV delay and
VV interval in CRT.
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